Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

NEWS

Quantum Biopharma Announces Closing of First Tranche
Friday, 13th December at 7:00 pm
TORONTO, ONTARIO / ACCESSWIRE / December 13, 2024 / Quantum BioPharma Ltd. (NASDAQ: QNTM)(CSE: QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce that it has closed an initial tranche ("First Tranche") of the offering announced on December 5, 2024 (the "December 5 NR") and has issued 500 Debenture Units (as defined in the December 5 NR) for $500,000.
The Company will use the proceeds from the First Tranche for the ongoing development of the Company's business model and for general working capital purposes.
All securities issued in the First Tranche are subject to a statutory hold period of four months and one day from the date of issuance.
The Company's obligations under the Debentures (as defined in the December 5 NR) are no longer collaterally secured by general security from the Company.
All amounts in this press release are expressed in Canadian dollars.
The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
1
Translate
Report
4124 Views
Comment
Sign in to post a comment